D. Chandratilleke et al., EFFECTS OF IN-VIVO THYROID-HORMONE TREATMENT ON THE EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON AVIAN SPLENOCYTES, International journal of immunopharmacology, 18(3), 1996, pp. 203-210
Comell K strain chickens received a diet supplemented with 0, 0.1 and
1.0 ppm T-3 from the day of hatching. At 28 days of age, splenocyte su
spensions were prepared and analyzed by flow cytometry for interleukin
-2 receptor (IL-2R) and CD3 expression. The low T-3 dose increased the
percentage of resting small cells expressing IL-2R while the mean flu
orescence for this marker was enhanced only after mitogenic activation
. This treatment did not alter the number of larger cells positive for
IL-2R but did increase their mean fluorescence following mitogenic ac
tivation. The high T-3 dose depressed the numbers of cells positive fo
r IL-2R and their mean fluorescence amongst all splenocyte preparation
s. Both levels of T-3 enhanced the numbers of CD3-positive cells in al
l cell preparations. These results suggest that the IL-2R expression c
an be modulated by in vivo T-3 supplementation and that these correlat
e with the previously demonstrated changes in IL-2-like activity. The
regulation of IL-2R expression provides one mechanism through which th
yroid status may regulate immune function.